IRCT20220211053992N22招募中Unknown
In vivo fasted-state bioequivalence study of Tenofovir Alafenamide 25mg tablets manufactured by Shari Pharmaceutical Co. compared to innovator product
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- All
入选标准
- •General Health (in terms of Liver, Heart and Kidney)
- •Age (18-59 years old)
排除标准
- •History of cardiovascular, liver and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
尚未招募
Unknown
Investigating the in vivo bioequivalence of Tetrabenazine 25 mgIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N29Tabriz University of Medical Sciences24
招募中
不适用
Bioequivalence study of Tinidazole 500 mg tabletIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N17Tabriz University of Medical Sciences24
尚未招募
Unknown
In vivo Bioequivalence study of Famotidine tabletIRCT20220211053992N35Tabriz University of Medical Sciences24
尚未招募
Unknown
In vivo Bioequivalence study of Levodopa/benserazide tabletsIRCT20220211053992N32Tabriz University of Medical Sciences24
尚未招募
Unknown
In vivo Bioequivalence study of Levodopa/benserazide tabletsIRCT20220211053992N34Tabriz University of Medical Sciences24